This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
Resumen de acción DFFN
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body’s ability to deliver oxygen.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Competidores de Diffusion Pharmaceuticals Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$7.59 |
| 52 Week High | US$14.37 |
| 52 Week Low | US$4.14 |
| Beta | 1.76 |
| 1 Month Change | 64.82% |
| 3 Month Change | 26.82% |
| 1 Year Change | -26.88% |
| 3 Year Change | -91.04% |
| 5 Year Change | -98.26% |
| Change since IPO | -99.66% |
Noticias y actualizaciones recientes
Recent updates
Diffusion Pharmaceuticals GAAP EPS of -$2.06 misses by $0.02
Aug 12We Think Diffusion Pharmaceuticals (NASDAQ:DFFN) Needs To Drive Business Growth Carefully
Feb 25
Companies Like Diffusion Pharmaceuticals (NASDAQ:DFFN) Are In A Position To Invest In Growth
Nov 12We're Not Very Worried About Diffusion Pharmaceuticals' (NASDAQ:DFFN) Cash Burn Rate
Jun 25Diffusion Pharmaceuticals EPS misses by $0.02
May 10We're Hopeful That Diffusion Pharmaceuticals (NASDAQ:DFFN) Will Use Its Cash Wisely
Mar 08Here's Why We're Watching Diffusion Pharmaceuticals' (NASDAQ:DFFN) Cash Burn Situation
Nov 23Rentabilidad de los accionistas
| DFFN | US Biotechs | Mercado US | |
|---|---|---|---|
| 7D | 44.2% | 4.4% | 0.6% |
| 1Y | -26.9% | 2.8% | 23.9% |
Rentabilidad vs. Industria: DFFN underperformed the US Biotechs industry which returned 3.5% over the past year.
Rentabilidad vs. Mercado: DFFN underperformed the US Market which returned 1% over the past year.
Volatilidad de los precios
| DFFN volatility | |
|---|---|
| DFFN Average Weekly Movement | 9.1% |
| Biotechs Industry Average Movement | 11.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: DFFN's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: DFFN's weekly volatility (9%) has been stable over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2001 | 13 | Bob Cobuzzi | www.diffusionpharma.com |
Resumen de fundamentos de Diffusion Pharmaceuticals Inc.
| Estadísticas fundamentales de DFFN | |
|---|---|
| Capitalización bursátil | US$13.47m |
| Beneficios(TTM) | -US$13.08m |
| Ingresos (TTM) | n/a |
0.0x
Ratio precio-ventas (PS)-1.2x
Ratio precio-beneficio (PE)¿Está DFFN sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de DFFN | |
|---|---|
| Ingresos | US$0 |
| Coste de los ingresos | US$0 |
| Beneficio bruto | US$0 |
| Otros gastos | US$13.08m |
| Beneficios | -US$13.08m |
Últimos beneficios comunicados
Jun 30, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -6.41 |
| Margen bruto | 0.00% |
| Margen de beneficio neto | 0.00% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado DFFN a largo plazo?
Ver rendimiento histórico y comparativa